Dr Reddy's Laboratories Ltd shares were down 1.3% at ₹1,239.90 ahead of its Q1FY26 results on July 23. Analysts expect growth in revenue and profit, with technicals showing consolidation and weak momentum. A bounce toward ₹1,300-1,360 is possible if support holds. A break below ₹1,230 may trigger further downside.